APEXIAN PHARMACEUTICALS, INC.

Profile

Company Names

APEXIAN PHARMACEUTICALS, INC.
APEX THERAPEUTICS, INC.

Addresses

20 N. MERIDIAN STREET, SUITE 805, INDIANAPOLIS, IN 46204

20 N. MERIDIAN STREET, SUITE 801, INDIANAPOLIS, IN 46204

Phone Numbers

317-684-9196
317-965-7712

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$7,726,534.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2019-03-18 
$150,000.00 
$2,000,000.00 
$1,850,000.00 
Equity 
5
2017-07-31 
$2,800,000.00 
INDEFINITE 
INDEFINITE 
Equity 
4
2016-10-07 
$1,262,635.00 
$1,500,000.00 
$237,365.00 
Equity 
3
2015-12-16 
$750,000.00 
$750,000.00 
$0.00 
Debt 
2
2015-06-09 
$275,000.00 
$650,000.00 
$375,000.00 
Equity 
1
2012-10-15 
$2,488,899.00 
$2,500,000.00 
$11,101.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
 
BARNARD 
DIRECTOR
IKOTECH, LLC   |  FLOWCO INC   |  YOURENCORE INC   |  APEX THERAPEUTICS, INC.   |  APEXIAN PHARMACEUTICALS, INC.
JOHN 
H. 
BARNARD 
DIRECTOR
APEX THERAPEUTICS, INC.   |  AIT BIOSCIENCE, LLC
DAVID 
 
BROECHER 
DIRECTOR
APEX THERAPEUTICS, INC.
DAVID 
 
BROECKER 
EXECUTIVE OFFICER, DIRECTOR
APEX THERAPEUTICS, INC.   |  APEXIAN PHARMACEUTICALS, INC.   |  INSCOPE MEDICAL SOLUTIONS, INC.
STEVE 
 
CARCHEDI 
EXECUTIVE OFFICER, DIRECTOR
BIONUMERIK PHARMACEUTICALS, INC.   |  APEXIAN PHARMACEUTICALS, INC.   |  ALLARITY THERAPEUTICS, INC.
MARTIN 
F. 
HASLANGER 
DIRECTOR, EXECUTIVE OFFICER
APEX THERAPEUTICS, INC.
MARTIN 
 
HASLANGER, PHD 
DIRECTOR
APEX THERAPEUTICS, INC.   |  APEXIAN PHARMACEUTICALS, INC.
MARK 
R. 
KELLEY 
DIRECTOR, EXECUTIVE OFFICER
APEX THERAPEUTICS, INC.
MARK 
R. 
KELLEY, PHD 
DIRECTOR
APEXIAN PHARMACEUTICALS, INC.
MARK 
 
KELLY, PHD 
EXECUTIVE OFFICER, DIRECTOR
APEX THERAPEUTICS, INC.
MARK 
R. 
KELLY, PHD 
EXECUTIVE OFFICER, DIRECTOR
APEX THERAPEUTICS, INC.   |  APEXIAN PHARMACEUTICALS, INC.
RICHARD 
 
MESSMAN, MD 
EXECUTIVE OFFICER
APEX THERAPEUTICS, INC.
RICHARD 
 
MESSMANN 
EXECUTIVE OFFICER
PRONAI THERAPEUTICS INC   |  APEXIAN PHARMACEUTICALS, INC.
ROGER 
 
MILLER 
EXECUTIVE OFFICER
ALTERNA CORE CAPITAL ASSETS FUND LP   |  ALTERNA CORE CAPITAL ASSETS FUND II, L.P.   |  APEX THERAPEUTICS, INC.   |  APEXIAN PHARMACEUTICALS, INC.   |  MORRIS STATE BANCSHARES, INC.
HOMER 
 
PEARCE 
DIRECTOR
KYLIN THERAPEUTICS INC   |  APEX THERAPEUTICS, INC.   |  APEXIAN PHARMACEUTICALS, INC.
HOMER 
L. 
PEARCE 
DIRECTOR, EXECUTIVE OFFICER
SUNESIS PHARMACEUTICALS INC   |  APEX THERAPEUTICS, INC.   |  BIONUMERIK PHARMACEUTICALS, INC.
HOMER 
 
PEARCE, PHD 
DIRECTOR
APEXIAN PHARMACEUTICALS, INC.
TIMOTHY 
 
TICHENOR 
EXECUTIVE OFFICER
GRAND RIVER ASEPTIC MANUFACTURING, INC.   |  APEXIAN PHARMACEUTICALS, INC.
TIMOTHY 
J. 
TICHENOR 
EXECUTIVE OFFICER
YOURENCORE INC   |  APEX THERAPEUTICS, INC.   |  GRAND RIVER ASEPTIC MANUFACTURING, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-03-25
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2019-03-18 
2018-07-11
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2017-07-31 
2016-12-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-10-07 
2016-02-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-12-16 
2015-06-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-09 
2013-06-20
D/A
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2012-10-15 
2012-10-29
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2012-10-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#